Never miss another update

Subscribe Today!

Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence

GENEVA, SWITZERLAND / ACCESSWIRE / November 24, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (“ Relief “), announced today that it has signed a collaboration agreement (the “ Collaboration “) with InveniAI LLC (“ InveniAI “), a U.S. based company that has pioneered the application of artificial intelligence and machine learning across biopharma… Read More »Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence

The post Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence appeared on Stocks News Feed.

Posted in

The Markets Today